Evaxion A (EVAX) Capital Expenditures (2020 - 2022)
Evaxion A's (EVAX) quarterly Capital Expenditures came in at -$83000.0 in Q2 2022, up 89.52% YoY from -$43794.8 in Q2 2021, and up 54.14% on a QoQ basis from -$181000.0 in Q1 2022.
Evaxion A (EVAX) Capital Expenditures (2020 - 2022) Analysis & Trends
Evaxion A (EVAX) has 3 years of Capital Expenditures data on file, last reported at -$83000.0 in Q2 2022.
- Quarterly Capital Expenditures rose 89.52% year-over-year to -$83000.0 in Q2 2022, while the trailing twelve-month figure through Jun 2022 was -$2.2 million (down 78.1% YoY) and the FY2025 annual result came in at $11000.0, changed N/A from the prior year.
- Capital Expenditures climbed to -$83000.0 in Q2 2022, from -$181000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of -$64000.0 in Q1 2020 to a low of -$1.1 million in Q3 2021.
- A 3-year average of -$334500.0 and a median of -$132000.0 in 2022 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2021 — Capital Expenditures plunged 1378.95% — and 2022, when it jumped 89.52%.
- Tracing EVAX's Capital Expenditures over 3 years: stood at -$76000.0 in 2020, then sank by 1378.95% to -$1.1 million in 2021, then soared by 92.62% to -$83000.0 in 2022.
- The last three Capital Expenditures figures came in at -$83000.0 (Q2 2022), -$181000.0 (Q1 2022), and -$1.1 million (Q3 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 86.29 Bn | 78.30 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 65.17 Bn | 59.98 Bn | 1.37 Bn | - |
| 4 | Moderna | 61.38 Bn | 56.24 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 42.18 Bn | 37.09 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 30.99 Bn | 27.68 Bn | 992.69 Mn | 34.68 Mn |
| 7 | BioNTech SE | 28.45 Bn | 10.05 Bn | 668.28 Mn | -73.57 Mn |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn | 6.26 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 251.02 Mn |
| 10 | Evaxion A | 27.52 Mn | 27.52 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -83,000.00 |
| Jun 30, 2022 | -83,000.00 |
| Mar 31, 2022 | -181,000.00 |
| Mar 31, 2022 | -181,000.00 |
| Sep 30, 2021 | -1.12 Mn |
| Sep 30, 2021 | -1.12 Mn |
| Jun 30, 2021 | -792,000.00 |
| Jun 30, 2021 | -792,000.00 |
| Mar 31, 2021 | -282,000.00 |
| Mar 31, 2021 | -282,000.00 |
| Sep 30, 2020 | -76,000.00 |
| Sep 30, 2020 | -76,000.00 |
| Jun 30, 2020 | -74,000.00 |
| Jun 30, 2020 | -74,000.00 |
| Mar 31, 2020 | -64,000.00 |
| Mar 31, 2020 | -64,000.00 |